| |
 |
Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer
|
| |
|
pp.481-499 (19) Authors: Jing Peng, Surojeet Sengupta, V. Craig Jordan |
| |
|
|
| |
|
Actual and Potential Agents and Biomarkers in the Treatment of Cancer
|
| |
|
pp.500-516 (17) Authors: M. P. Carrera, M. J. Ramirez-Exposito, J. M. Martinez-Martos |
| |
|
|
| |
|
Role of Oxygen in Cancer: Looking Beyond Hypoxia
|
| |
|
pp.517-525 (9) Author: Miguel Lopez-Lazaro |
| |
|
|
| |
|
The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
|
| |
|
pp.526-542 (17) Authors: Andrew J. Wiemer, Raymond J. Hohl, David F. Wiemer |
| |
|
|
| |
|
Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy?
|
| |
|
pp.543-549 (7) Authors: J. Thomas DeLigio, Aneliya Velkova, Diego A.R. Zorio, Alvaro N.A. Monteiro |
| |
|
|
| |
|
The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies
|
| |
|
pp.550-559 (10) Authors: Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka, Osamu Yamada |
| |
|
|
| |
|
The Effect of Lipoic Acid on Macro and Trace Metal Levels in Living Tissues Exposed to Oxidative Stress
|
| |
|
pp.560-568 (9) Authors: Harun Ciftci, Unal Bakal |
| |
|
|
| |
|
Role of Tyrosine Kinase Inhibitors in Lung Cancer
|
| |
|
pp.569-575 (7) Authors: J. Ansari, D. H. Palmer, D. W. Rea, S. A. Hussain |
| |
|
|
| |
|
Control of Melanoma Invasiveness by Anticollagenolytic Agents: A Reappraisal of an Old Concept
|
| |
|
pp.576-597 (22) Authors: Erika Bourguet, Janos Sapi, Herve Emonard, William Hornebeck |
| |
|
|
